Donation of Contraceptive Products through Special Import Permits: A Case Study in Zambia and Nigeria
Abstract
Introduction: Securing a special import permit for the donation of an unregistered contraceptive product can be a viable option to import the product in an expedited manner. However, this process can be difficult due to varying country requirements and the availability of accurate and timely information.
Case description: This paper will explore the process for securing import permits for donated contraceptive products in Zambia and Nigeria, comparing national guidelines to applicant experiences and providing recommendations to future applicants.
Discussion and evaluation: In practice, application requirements and timelines for special import permits in Zambia and Nigeria differed from national guidelines. Despite these differences, special import permits can be secured more quickly than formal product registration, which is a slower but more sustainable solution.
Conclusion: Due to a lack of comprehensive and up-to-date guidelines online for some low- and middle-income countries (LMICs), the regulatory community is encouraged to share their experiences with special import permit application processes.
Downloads
References
http://apps.who.int/gb/ebwha/pdf_files/EB142/B142_13-en.pdf
2) World Health Organization. Improving the Quality of Medical Products for Universal Access [Internet]. [Place unknown]: Switzerland: WHO; 2016 Nov.24 [cited 2019 May 10]. Available from:
https://www.who.int/medicines/regulation/fact-figures-qual-med/en/
3) World Health Organization. Guidelines for Medicine Donations [Internet]. Switzerland: WHO; 2010 [cited 2019 May 10]. Available from WHO Press:
https://apps.who.int/iris/bitstream/handle/10665/44647/9789241501989_eng.pdf?sequence=1
4) Pharmaceutical Regulatory Authority, Zambia. Guidelines for Drug Donations (including ARVs) to the Republic of Zambia [Internet]. Zambia: 2005 Feb. [cited 2019 May 13]. Available from:
https://www.mm3admin.co.za/documents/docmanager/2D5ED792-878C-4371-9575-8281A96BBB26/00031197.pdf
5) Federal Ministry of Health, Nigeria. Guidelines for Donations of Medicines and Health Care Equipment in [Internet]. Nigeria: Federal Ministry of Health; Apr.2007 [cited 2019 May 10]. Available from:
https://www.health.gov.ng/doc/DDG.pdf
6) National Agency for Food & Drug Administration & Control (NAFDAC). Guidelines for Issuance of Approval to Import Donated Items by NGOs [Internet]. Lagos state: NAFDAC; 2018 Jun.01 [cited 2019 May 10]. Available from:
https://www.nafdac.gov.ng/wp-content/uploads/Files/Resources/Guidelines/PORTINSPECTION_GUIDELINES/Guideline-For-Approval-To-Import-Donated-Items-By-Non-Governmental-Organizations.pdf
7) National Agency for Food & Drug Administration & Control (NAFDAC). Guidelines for clearing of Imported Donated Items at Ports of Entry in Nigeria [Internet]. Lagos state: NAFDAC; 2018 Jun.01 [cited 2019 May 13]. Available from:
https://www.nafdac.gov.ng/wp-content/uploads/Files/Resources/Guidelines/PORTINSPECTION_GUIDELINES/Guidelines-for-Clearance-of-Imported-Donated-Items-at-Ports-of-Entry-in-Nigeria.pdf
8) National Agency for Food & Drug Administration and Control. Tariff [Internet]. Lagos state: NAFDAC; 2019 Jun.01 [cited 2020 Sep.1]. Available from:
https://www.nafdac.gov.ng/wp-content/uploads/Publications/Others/NAFDAC-2019-Tariff_hyperlinked_Final.pdf
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
